April 18, 2017 / 5:18 AM / 4 months ago

BRIEF-Valneva signs new EB66 commercial license with Bavarian Nordic

April 18 (Reuters) - Valneva SE:

* Announces signing of a new EB66 commercial license with Bavarian Nordic

* Valneva's EB66 cell-line licensed to Bavarian Nordic for MVA-BN based product candidates

* Valneva to support process development

* The agreement grants Bavarian Nordic the rights to develop and commercialize multiple poxvirus-based vaccines on the EB66 cell-line Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below